A 55-year-old man was admitted to our hospital with fever and vomiting. Abdominal computed tomography (CT) revealed multiple low density masses in the liver. A diagnosis of primary adenosquamouscarcinoma of the liver was confirmed by histological examination of a necropsy specimen. The present case showed leukocytosis and hypercalcemia with high levels of serum granulocyte-colony-stimulating factor (G-CSF) and parathyroid hormone related 
Introduction
Adenosquamous carcinoma (ASC) is a tumor composed of both squamouscell carcinoma and adenocarcinoma components. Primary adenosquamouscarcinoma of the liver is rare. All the reported cases were in an advanced stage and had a poor prognosis. On the other hand, it is well known that the paraneoplastic syndromesof leukocytosis and hypercalcemia sometimesoccur in malignancies. Thecoexistence of leukocytosis and hypercalcemia in certain cancers has been reported ( 14-1 8) . Granulocyte-colony-stimulating factor (G-CSF) and parathyroid hormone related protein (PTHrP) are responsible for these types of paraneoplastic syndromes. Wereport here a rare case of primary adenosquamouscarcinoma of the liver associated simultaneously with leukocytosis and hypercalcemia, with some discussion of the literature.
Case Report A55-year-old manwas admitted to our hospital for a lowgrade fever and vomiting on June 5, 1999. He had no history of blood transfusion. His family history was not contributory. On physical examination, his body temperature was 37.8°C, his blood pressure was 140/72 mmHg, and his pulse rate was 74/ min and regular. There was no jaundice. Cervical and supraclavicular lymph nodes were not palpable. Abdominal examination revealed a tender liver, extending seven finger-breadths belowthe right costal margin. Therewasno ascites. Table 1 shows the laboratory values on admission. Erythrocyte sedimentation rate (ESR) was 106 mm/h and C-reactive protein (CRP) was 17 mg/dl. Total white blood cell (WBC) count was 27,500/jil, absolute neutrophil (segment and bands) count (ANC) was 23,500/|il (85.5%). Blast and immature cells were not found in the peripheral blood. Blood chemistry was within the normal range except for elevated aspartate amionotransferase (AST) and alkaline phosphatase (ALP).
Hepatitis B viral surface antigen and hepatitis C viral antibody were negative. The levels of serum a-fetoprotein (AFP) and carcinoembryonic antigen (CEA) were within the normal range. The levels of serum carbohydrate antigen 19-9 (199.7 U/ml, normal range <37 U/ml) and squamous cell carcinoma related antigen (6.6 ng/ml, normal range <1.5 ng/ml) were moderately high. Protein induced by vitamin K antagonist-II (PIVKA-II) was also elevated to 45 mAU/ml(normal range <40 mAU/ml). There was markedly elevated ANC, although no evidence of active infectious disease was found. His serum G-CSFwas el- evated to 79 pg/ml (normal range <6-21 pg/ml). The serum level of interleukin la (10.5 pg/ml, normal range <7.8 pg/ml) and interleukin 6 (95.7 pg/ml, normal range <4 pg/ml) were high, while interleukin lp (<10 pg/ml) was within the normal range. On August 2, 1999, his serum level of calcium was elevated to 12.6 mg/dl and the serum level of PTHrP was high ( 10 PMol//, normal range <0.6 PMol//), while serum intact PTH was low (6 pg/ml, normal range 10-65 pg/ml). Computed tomograghy (CT) showed multiple nodules located in the anterior and medial segment of the liver (Fig. 1) . A fine-needle biopsy of the liver tumor revealed squamous cell carcinoma. Since there wasno evidence of other primary sites, a diagnosis of primary squamous cell carcinoma of the liver was made. However, because of the rapid development of the liver tumor, the patient died of liver failure 64 days after admission to the hospital. Uponautopsy, the liver weighed 4,300 g, and showed a solid whitish tumor, 5 cmin diameter, located in the anterior segment of the liver, with diffuse small nodules invading into two lobes (Fig. 2) . Histologic examination revealed that the liver tumor was composedmainly of squamous cell carcinoma and partly of focal areas of adenocarcinoma (Fig. 3) . No carcinomas were found in the gallbladder, stomach, pancreas or other organs. Finally, a diagnosis of primary ASCwas confirmed. In addition, the tumor was immunostained using antisera against G-CSF (Fig. 4) and PTHrP (Fig. 5) . Some tumor cells were positively stained. This demonstrated that the tumor produced G-CSF and PTHrP. liver tumorwith similar composite histology of areas of adenocarcinoma and squamouscell carcinoma, such as ASC, mucoepidermoidcarcinoma or adenoacanthoma, have been reported (2) (3) (4) . Amongthose 34 cases, ASC was found in only 26 cases, including the present case, with definitive histological studies. This histologic type of hepatic ASCis not consistently found in a particular site within the liver and shows no evidence of being related to hepatitis virus. ASC typically develops in the gallbladder, the extrahepatic bile duct, or the pancreas, but rarely in the liver. The diagnosis of primary ASCof the liver should be madewhenboth malignant squamousand glandular elements are present, and primary cancers of the gallbladder, pancreas, extrahepatic bile duct, or lungs should be ruled out. ASCof the liver is currently assumed to originate from the intrahepatic bile duct. This tumor is considered to be a subtype of cholangiocarcinoma, whichis not a common type of liver malignancy. However, the histogenesis of the tumor is still largely unknown.Someinvestigators support the theory that the tumor might develop by transformation of pre-existing adenocarcinoma in the transitional areas between adenocarcinoma and squamous cell carcinoma (5, 6) . Concerning the pathogenesis, somereports have demonstrated that ASCis associated with hepatolithiasis (7, 8) Concerning the biological relationship of G-CSF and tumor growth, it has been reported that G-CSFalso stimulates nonhematopoietic tumor cells. G-CSF-producing tumor cells expressed a G-CSFreceptor which induces tumor cell growth by G-CSFvia the autocrine pathways (1 1). For this reason G-CSF-producing tumors usually grow rapidly and the prognosis is extremely unfavorable. Recent studies have shownthat the G-CSF producing tumor is a multi-cytokine-producing tumor which secretes IL-1 and IL-6 in addition to G-CSF (12) . IL-1 levels may exceed those of G-CSFand IL-6. The present case also showed elevated serum levels of IL-1 and IL-6. This suggests that IL-1 mayplay an important role in the regulation of G-CSF and IL-6 production in this G-CSF producing hepatic tumor.
Furthermore, hypercalcemia also occurred in the present case. His serum PTHrPlevels were elevated. PTHrPhas been identified as a major causative peptide for hypercalcemia in malignancies (13) . The immunohistochemistry study of the present tumor tissue demonstrated positive staining for PTHrP. This suggests that the tumor produces PTHrPwhich is responsible for hypercalcemia. The concomitant existence of leukocytosis and hypercalcemia has been reported in cancers of the oral mucosa (14) , thyroid (15) , lungs (16) , gallbladder (17) , and cholangiocarcinoma (18) . It is still uncertain whether leukocytosis and hypercalcemia are complicated randomly or if there are some factors commonlyregulating them. IL-l is a osteoclast-activating factor which causes hypercalcemia synergistically with PTHrP (19) . IL-1 is also a hemopoetin-1 , which potentiates G-CSF-induced leukocytosis. Sato et al (19) reported that IL-1a has dual effects on the development of leukocytosis and hypercalcemia. However, the detailed mechanism of hypercalcemia-leukocytosis syndromeis not clear. In order to elucidate it, further investigation will be necessary.
